🇺🇸 FDA
Pipeline program

Pioglitazone

01-00-TL-OPI-520

Approved small_molecule completed

Quick answer

Pioglitazone for Diabetes Mellitus is a Approved program (small_molecule) at TAKEDA PHARMACEUTICAL CO LTD with 9 ClinicalTrials.gov record(s).

Program details

Company
TAKEDA PHARMACEUTICAL CO LTD
Indication
Diabetes Mellitus
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials